<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Investigational New Drug Applications for Biological Products; Bioequivalence Regulations; Technical Amendment</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Investigational New Drug Applications for Biological Products; Bioequivalence Regulations; Technical Amendment</h1>
    <p class="timestamp">Published: 2016-03-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is amending its regulations to update the address for applicants to submit investigational new drug applications (INDs) for biological products regulated by the Center for Drug Evaluation and Research (CDER). FDA is also amending its regulations on the criteria and evidence to assess actual and potential bioequivalence problems (bioequivalence regulations) to correct a typographical error. FDA is taking this action to ensure accuracy and clarity i...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-06886</p>
    <p><strong>Publication Date:</strong> 2016-03-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/03/28/2016-06886/investigational-new-drug-applications-for-biological-products-bioequivalence-regulations-technical">https://www.federalregister.gov/documents/2016/03/28/2016-06886/investigational-new-drug-applications-for-biological-products-bioequivalence-regulations-technical</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-06886</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
